VIRI Stock Discussion

Dogwood Therapeutics, Inc. Description

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Pain Antiviral Drug Rheumatology Fibromyalgia Antiviral Therapies